Daniel Ferguson
Impact in
- Epidemiology top 10%
- Liver Disease Diagnosis and Treatment
- Adipokines, Inflammation, and Metabolic Diseases
-
- Diet, Metabolism, and Disease
Papers in
-
- Metabolism, Diabetes, and Cancer 3
- Physiology 10
- Adipose Tissue and Metabolism 8
- Diet and metabolism studies 3
- Co-authors
- Brian N. Finck (13 shared papers)Charles Harris (5 shared papers)Irina Hutson (4 shared papers)Gretchen A. Meyer (3 shared papers)Kyle S. McCommis (5 shared papers)Richard Lee (2 shared papers)Robert N. Helsley (2 shared papers)Yun‐Rak Choi (1 shared paper)
- Journals
- Endocrinology (3 papers)Biochemical and Biophysical Research Communications (2 papers)iScience (1 paper)Diabetes (1 paper)Cell Reports (1 paper)
- Partner nations
- United StatesSouth KoreaChina
In The Last Decade
Daniel Ferguson
21 papers receiving 790 citations
Daniel Ferguson's Hit Papers
Peers
Comparison fields: 5 of 76
- Epidemiology 369
- Endocrinology, Diabetes and Metabolism 170
- Biochemistry 68
- Hepatology 74
- Physiology 178
Countries citing papers authored by Daniel Ferguson
This map shows the geographic impact of Daniel Ferguson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Ferguson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Ferguson more than expected).
Fields of papers citing papers by Daniel Ferguson
This network shows the impact of papers produced by Daniel Ferguson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Ferguson. The network helps show where Daniel Ferguson may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Ferguson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus Hit paper breakdown → | 2021 | 342 |
| 2 | 2020 | 127 | |
| 3 | 2017 | 93 | |
| 4 | 2023 | 32 | |
| 5 | 2016 | 28 | |
| 6 | 2022 | 27 | |
| 7 | 2021 | 26 | |
| 8 | 2019 | 23 | |
| 9 | 2017 | 16 | |
| 10 | 2020 | 15 | |
| 11 | 2023 | 14 | |
| 12 | 2018 | 10 | |
| 13 | 2021 | 8 | |
| 14 | 2024 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2023 | 6 | |
| 18 | 2024 | 4 | |
| 19 | 2025 | 1 | |
| 20 | 2021 | 1 |
About Daniel Ferguson
Daniel Ferguson is a scholar working on Molecular Biology, Physiology, Epidemiology, Biochemistry and Surgery, having authored 22 papers that have together received 794 indexed citations. Recurring topics across this work include Adipose Tissue and Metabolism (8 papers), Liver Disease Diagnosis and Treatment (5 papers), Metabolism and Genetic Disorders (4 papers), Lipid metabolism and biosynthesis (4 papers), Diet, Metabolism, and Disease (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Diet and metabolism studies (3 papers) and Adipokines, Inflammation, and Metabolic Diseases (3 papers). The work is most often cited by research in Epidemiology (369 citations), Endocrinology, Diabetes and Metabolism (170 citations), Biochemistry (68 citations), Hepatology (74 citations) and Physiology (178 citations). Daniel Ferguson has collaborated with scholars based in United States, South Korea and China. Frequent co-authors include Brian N. Finck, Charles Harris, Irina Hutson, Gretchen A. Meyer, Kyle S. McCommis, Richard Lee, Robert N. Helsley, Yun‐Rak Choi, Kelsey H. Collins and Christine T. N. Pham. Their work appears in journals such as Endocrinology, Biochemical and Biophysical Research Communications, iScience, Diabetes and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.